Unknown

Dataset Information

Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape.


ABSTRACT:

Background

Adrenocortical carcinoma (ACC) is a rare, often-aggressive neoplasm of the adrenal cortex, with a 14-17 month median overall survival. We asked whether tumors from patients with advanced or metastatic ACC would offer clues as to putative genes that might have critical roles in disease progression or in more aggressive disease biology.

Methods

We conducted comprehensive genomic and expression analyses of ACCs from 43 patients, 30 female, and 42 from metastatic sites, including deep sequencing, copy number analysis, mRNA expression and microRNA arrays.

Results

Copy number gains and losses were similar to that previously reported for ACC. We identified a median mutation rate of 3.38 per megabase (Mb). The mutational signature was characterized by a predominanc

SUBMITTER: Fojo T 

PROVIDER: S-EPMC7640690 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature